Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Feb;59(2):160-5.
doi: 10.1136/jcp.2004.023598.

cDNA microarray analysis of cancer associated gene expression profiles in malignant peripheral nerve sheath tumours

K Karube  1 , K Nabeshima, M Ishiguro, M Harada, H Iwasaki
Affiliations

cDNA microarray analysis of cancer associated gene expression profiles in malignant peripheral nerve sheath tumours

K Karube et al. J Clin Pathol. 2006 Feb.

Abstract

Background: Malignant peripheral nerve sheath tumour (MPNST) is a highly aggressive malignancy that arises within peripheral nerves, and is associated with poor prognosis. Little is known about the underlying biology of MPNST, especially the mechanisms involved in cell proliferation, invasion, or escape from apoptosis.

Aims: To identify genes differentially expressed in MPNST compared with benign tumours, such as neurofibromas and schwannomas, by means of cDNA microarray analysis.

Methods: Six MPNST cases and five benign cases (three schwannomas and two neurofibromas) were analysed.

Results: Six genes (keratin 18, survivin, tenascin C, adenosine deaminase, collagen type VIa3, and collagen type VIIa1) were significantly upregulated in MPNST, whereas one gene, insulin-like growth factor binding protein 6, was downregulated in MPNST. Survivin and tenascin C expression was validated by reverse transcription polymerase chain reaction. Immunohistochemistry confirmed upregulation of survivin in MPNST at the protein level in six of eight cases compared with benign tumours. Tenascin C was also expressed at the invasive front and tumorous stroma in all MPNST cases. MPNST cells expressed tenascin C in four of nine cases.

Conclusions: Survivin and tenascin C may be associated with the malignant potential of MPNST and could be considered as potential therapeutic targets.

PubMed Disclaimer

References

    1. Ducatman B S, Scheithauer B W, Piepgras D G.et al Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer 1986572006–2021. - PubMed
    1. Viskochil D, Buchberg A M, Xu G.et al Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell 199062187–192. - PubMed
    1. Wallace M R, Marchuk D A, Andersen L B.et al Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science 1990249181–186. - PubMed
    1. Daston M M, Scrable H, Nordlund M.et al The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells, and oligodendrocytes. Neuron 19928415–428. - PubMed
    1. Skotheim R I, Kallioniemi A, Bjerkhagen B.et al Topoisomerase‐II alpha is upregulated in malignant peripheral nerve sheath tumors and associated with clinical outcome. J Clin Oncol 2003214586–4591. - PubMed

MeSH terms